ISSN 2149-3235 | E-ISSN 2149-3057
RELATED ARTICLES
Editorial
Relationship between preoperative PSA, PSA density, free/total PSA ratio and unfavorable pathological features of surgical specimen and biochemical failure in patients who have undergone radical prostatectomy
(Turk J Urol 2010; 36: 226-232)
Changes in patients’ quality of life following treatment of localized and metastatic prostate cancer
(Turk J Urol 2011; 37: 184-190)
Is substaging necessary in patients with pathological stage T2 prostate cancer?
(Turk J Urol 2011; 37: 288-293)
DOI: 10.5152/tud.2011.055
Diagnosis and management of biochemical recurrence in patients with prostate cancer who received definitive treatment
(Turk J Urol 2011; 37: 295-302)
Salvage therapies for radiorecurrent prostate cancer
(Turk J Urol 2011; 37: 350-356)
DOI: 10.5152/tud.2011.067
THE VALUE OF TRANSITIONAL ZONE PSA DENSITY IN THE DIAGNOSİS OF THE PROSTATIC CARCINOMA
(Turk J Urol 2001; 27: 270-274)
Case Report
Mandibular osteonecrosis due to bisphosphonate use
(Turk J Urol 2015; 41: 43-47)
DOI: 10.5152/tud.2015.90277
Prostatic adenocarcinoma with initial metastatic spread to the mandible
(Turk J Urol 2015; 41: 149-151)
DOI: 10.5152/tud.2015.36043
Paraneoplastic hyperbilirubinemia in metastatic prostate cancer and review of the current literature
(Turk J Urol ; : -)
DOI: 10.5152/tud.2018.52059
Supraclavicular lymph node as the first presentation and late skin metastasis: an unusual clinical course for prostate cancer
(Turk J Urol 2018; 44: 75-78)
DOI: 10.5152/tud.2017.29660
Giant renal metastasis from prostate cancer mimicking renal cell carcinoma
(Turk J Urol 2018; 44: 367-369)
DOI: 10.5152/tud.2017.39225
Giant renal metastasis from prostate cancer mimicking renal cell carcinoma
(Turk J Urol ; : -)
DOI: 10.5152/tud.2017.39225
Review
PI-RADS v2: Current standing and future outlook
(Turk J Urol 2018; 44: 189-194)
DOI: 10.5152/tud.2018.12144
Transrectal ultrasound-guided prostate biopsy: current approach
(Turk J Urol 2010; 36: 25-32)
The effect of modified Gleason grading on the score concordance between the Gleason scores of needle biopsy and radical prostatectomy specimens in prostatic carcinoma
(Turk J Urol 2010; 36: 333-338)
Small cell carcinoma of the genitourinary system
(Turk J Urol 2010; 36: 344-349)
Multiparametric magnetic resonance imaging: Overview of the technique, clinical applications in prostate biopsy and future directions
(Turk J Urol 2018; 44: 93-102)
DOI: 10.5152/tud.2018.56056
Original Article
Predictive values for extracapsular extension in prostate cancer patients with PSA values below 10 ng/mL
(Turk J Urol 2014; 40: 130-133)
DOI: 10.5152/tud.2014.00086
Prostate myths: What is the prostate awareness in the general male population in Turkey?
(Turk J Urol 2014; 40: 150-155)
DOI: 10.5152/tud.2014.80090
The effect of the presence of a high-grade tertiary Gleason pattern in radical prostatectomy specimens on histopathological results and failure of biochemical treatment
(Turk J Urol 2012; 38: 177-184)
DOI: 10.5152/tud.2012.038
The relationship between prostate size, patient age and prognostic factors in patients with prostate biopsy cancer detected
(Turk J Urol 2012; 38: 121-125)
DOI: 10.5152/tud.2012.027
Factors affecting recurrence and survival in patients who underwent radical prostatectomy for prostate cancer
(Turk J Urol 2011; 37: 1-8)
Relationship between serum PSA and testosterone levels in two different geographic regions of Turkey
(Turk J Urol 2011; 37: 9-13)
Laparoscopic radical prostatectomy for locally advanced prostate cancer: our initial results
(Turk J Urol 2011; 37: 14-19)
The relation between biochemical recurrence and surgical border positiveness and grading of prostate needle biopsy specimen following radical prostatectomy
(Turk J Urol 2010; 36: 1-6)
The impact of educational sessions provided on prostate cancer, and its screening tests on the knowledge level, and participation behavior of the individuals in questionnaire surveys
(Turk J Urol 2014; 40: 17-23)
DOI: 10.5152/tud.2014.80688
Our results of active surveillance for localized prostate cancer patients
(Turk J Urol 2013; 39: 1-5)
DOI: 10.5152/tud.2013.001
The importance of prostate volume in prostate needle biopsy
(Turk J Urol 2013; 39: 74-77)
DOI: 10.5152/tud.2013.019
The comparison of 6- and 12-core first prostate biopsy results in patients with prostate specific antigen level of 4-10 ng/mL
(Turk J Urol 2009; 35: 274-280)
Orexin expression in different prostate histopathologic examinations: Can it be a marker for prostate cancer? A preliminary result
(Turk J Urol 2013; 39: 78-83)
DOI: 10.5152/tud.2013.023
Serum testosterone levels, testis volume, and the risk of prostate cancer: are these factors related?
(Turk J Urol 2013; 39: 12-15)
DOI: 10.5152/tud.2012.003
Factors determining biochemical recurrence in low-risk prostate cancer patients who underwent radical prostatectomy
(Turk J Urol 2015; 41: 61-66)
DOI: 10.5152/tud.2015.65624
A prospective study of the efficacy of magnetic resonance spectroscopy imaging for predicting locally advanced prostate cancer
(Turk J Urol 2015; 41: 67-72)
DOI: 10.5152/tud.2015.81904
Radical perineal prostatectomy: Our initial experience
(Turk J Urol 2014; 40: 89-92)
DOI: 10.5152/tud.2014.45144
The level of knowledge and awareness about prostate cancer in the Turkish male and the relevant effective factors
(Turk J Urol 2016; 42: 134-139)
DOI: 10.5152/tud.2016.90235
Surgical site infections after radical prostatectomy: A comparative study between robot-assisted laparoscopic radical prostatectomy and retropubic radical prostatectomy
(Turk J Urol 2018; 44: 303-310)
DOI: 10.5152/tud.2018.03435
The importance of active surveillance, and immediate re-biopsy in low-risk prostate cancer: The largest series from Turkey
(Turk J Urol 2016; 42: 140-144)
DOI: 10.5152/tud.2016.47786
Diagnostic value of microRNAs in prostate cancer patients with prostate specific antigen (PSA) levels between 2, and 10 ng/mL
(Turk J Urol 2016; 42: 247-255)
DOI: 10.5152/tud.2016.52463
Robot-assisted radical prostatectomy in low- and high-risk prostate cancer patients
(Turk J Urol 2017; 43: 36-41)
DOI: 10.5152/tud.2016.09476
The factors predicting upgrading of prostate cancer by using International Society for Urological Pathology (ISUP) 2014 Gleason grading system
(Turk J Urol ; : -)
DOI: 10.5152/tud.2018.57946
Prognostic influence of 5 alpha reductase inhibitors in patients with localized prostate cancer under active surveillance
(Turk J Urol 2018; 44: 132-137)
DOI: 10.5152/tud.2017.39660
Assessment of prostate cancer with integrated CT-perfusion using a sector-wise approach
(Turk J Urol 2017; 43: 152-157)
DOI: 10.5152/tud.2017.11455
Does extent of prostate-specific antigen fluctuation can predict Gleason score upgrading in low-risk prostate cancer patients?
(Turk J Urol ; : -)
DOI: 10.5152/tud.2018.41017
Computed tomography based evaluation of prostatic fiducial marker migration between the periods of insertion and simulation
(Turk J Urol 2017; 43: 451-455)
DOI: 10.5152/tud.2017.29726
How localized is pathologically localized prostate cancer? The use of secondary circulating prostate cells as a marker of minimal residual disease and their association with patient outcome
(Turk J Urol 2017; 43: 456-461)
DOI: 10.5152/tud.2017.60251
Low free and bioavailable testosterone levels may predict pathologicallyproven high-risk prostate cancer: a prospective, clinical trial
(Turk J Urol 2017; 43: 289-296)
DOI: 10.5152/tud.2017.35467
Longer biopsy cores do not increase prostate cancer detection rate: A large-scale cohort study refuting cut-off values indicated in the literature
(Turk J Urol 2017; 43: 297-302)
DOI: 10.5152/tud.2017.03743
Brain metastases from prostate cancer: A single-center experience
(Turk J Urol ; : -)
DOI: 10.5152/tud.2018.74555
Does the prostate volume always effect cancer detection rate in prostate biopsy? Additional role of prostate-specific antigen levels: A retrospective analysis of 2079 patients
(Turk J Urol ; : -)
DOI: 10.5152/tud.2018.66909
General Urology
COMPARISON OF PATIENT COMFORT AND COMPLICATIONS OF TRANSRECTAL ULTRASONOGRAPHY GUIDED PROSTATE BIOPSIES USING 16 AND 18 GAUGE NEEDLES
(Turk J Urol 2005; 31: 119-122)
EFFECTS OF CHRONIC PROSTATITIS ON PROSTATE SPECIFIC ANTIGEN
(Turk J Urol 2001; 27: 350-355)
Endorectal magnetic resonance imaging in prostate pathologies
(Turk J Urol 2009; 35: 191-200)
Andrology
ERECTILE DYSFUNCTION AND TREATMENT AFTER RETROPUBIC RADICAL PROSTATECTOMY
(Turk J Urol 2005; 31: 186-196)
Laparoscopy
Operative, oncologic and functional reflections of surgical training and post-training practice in laparoscopic radical prostatectomy
(Turk J Urol 2009; 35: 230-234)
Endourology
LAPAROSCOPIC EXTRAPERITONEAL RADICAL PROSTATECTOMY: OUR FIRST EXPERIENCES
(Turk J Urol 2005; 31: 384-388)
Urooncology
EFFECT OF TRANSURETHRAL RESECTION OF PROSTATE (TURP) ON PROGRESSION TIME IN PATIENTS WITH ADVANCED PROSTATE CANCER RECEIVING MAXIMUM ANDROGEN BLOCKADE
(Turk J Urol 2005; 31: 474-478)
IS PROSTATE SPARING SURGERY A SAFE TECHNIQUE FOR RADICAL CYSTECTOMY WITH ORTHOTOPIC NEOBLADDER?
(Turk J Urol 2005; 31: 485-489)
THE RATE OF INCIDENTAL PROSTATE CANCER IN PATIENTS UNDERGOING RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER
(Turk J Urol 2005; 31: 490-494)
TREATMENT OPTIONS AFTER BRACHYTHERAPY FAILURE
(Turk J Urol 2005; 31: 170-177)
THE CORRELATION BETWEEN PSA AND NITRIC OXIDE VALUE IN BPH AND PROSTATIC CANCER PATIENTS
(Turk J Urol 2003; 29: 410-413)
PRE/POST MEAL PSA VALUES: SHOULD IT BE MEASURED IN PRE-MEAL BLOOD SERUM?
(Turk J Urol 2005; 31: 36-40)
PSA, PSA derivatives, proPSA and prostate health index in the diagnosis of prostate cancer
(Turk J Urol 2014; 40: 82-88)
DOI: 10.5152/tud.2014.94547
Other
THE EFFICACY OF INTRARECTALLY LOCAL ANESTHESIA WITH LIDOCAINE GEL ON THE COMFORT OF THE PATIENT DURING TRANSRECTAL ULTRASOUND-GUIDED 12 CORES PROSTATE BIOPSIES
(Turk J Urol 2003; 29: 159-163)
INTERMITTENT MAXIMUM ANDROGEN BLOCKADE IN ADVANCED PROSTATE CANCER
(Turk J Urol 2001; 27: 417-423)
IS PROSTATE SPECIFIC ANTIGEN IN THE PATIENTS WITH PRIMARY PROSTATE CANCER DIAGNOSED WITH BONE SCINTIGRAPHY?
(Turk J Urol 2001; 27: 433-436)
EVALUATION OF RISING PSA AFTER RADICAL PROSTATECTOMY
(Turk J Urol 2002; 28: 42-47)
THE EFFECTIVENESS OF FREE/TOTAL PSA RATIO IN EVALUATION OF PATHOLOGICAL STAGE AFTER RADICAL PROSTATECTOMY
(Turk J Urol 2003; 29: 258-263)
EARLY CATHETER REMOVAL AT 8TH POSTOPERATIVE DAY BY USING URETERAL CATHETERS IN RADICAL RETROPUBIC PROSTATECTOMY
(Turk J Urol 2003; 29: 264-267)
Uro-Oncology
THE USEFULNESS OF TRANSRECTAL ULTRASONOGRAPHY IN MEN WITH PROSTATE SPESIFIC ANTIGEN LEVELS 4.0 MG/ML OR LESS
(Turk J Urol 2005; 31: 178-181)
Invited Review
When prostate cancer remains undetectable: The dilemma
(Turk J Urol 2015; 41: 32-38)
DOI: 10.5152/tud.2015.91249
Score 3 prostate lesions: a gray zone for PI-RADS v2
(Turk J Urol 2017; 43: 237-240)
DOI: 10.5152/tud.2017.01058
Metabesity and urological cancers
(Turk J Urol 2017; 43: 410-413)
DOI: 10.5152/tud.2017.66502
Short Report
Biparametric MRI and 41 sector map for MRI/Transrectal ultrasound fusion biopsy to increase diagnostic accuracy of prostate cancer
(Turk J Urol 2018; 44: 453-454)
DOI: 10.5152/tud.2018.04406
Seperation of dorsal vein complex from the urethra by blunt finger dissection during radical retropubic prostatectomy
(Turk J Urol 2015; 41: 108-111)
DOI: 10.5152/tud.2015.67699
Systematic Review
Is extended pelvic lymph node dissection for prostate cancer the only recommended option? A systematic over-view of the literature
(Turk J Urol 2016; 42: 240-246)
DOI: 10.5152/tud.2016.52893
Key Words
Authors
All
Survey
AVES | Copyright © 2018 Turkish Association of Urology | Latest Update: 08.10.2018